Retail and institutional investors aren’t the only ones who used the fourth-quarter selloff last year as a buying opportunity.  Bristol-Myers Squibb (NYSE: BMY), one of the largest U.S. pharma companies by revenue, didn’t waste any time scooping up biotech Celgene (Nasdaq: CELG). Announced on January 3, the $74 billion acquisition is the second-largest pharmaceutical M&A deal ever (after the $87 billion merger of Warner-Lambert and Pfizer (NYSE: PFE) twenty years ago). Despite the price tag, it was still a bargain. Even though BMY offered a 53.7% premium to CELG’s closing price on January 2, the latter, which lost $30 per… Read More

Retail and institutional investors aren’t the only ones who used the fourth-quarter selloff last year as a buying opportunity.  Bristol-Myers Squibb (NYSE: BMY), one of the largest U.S. pharma companies by revenue, didn’t waste any time scooping up biotech Celgene (Nasdaq: CELG). Announced on January 3, the $74 billion acquisition is the second-largest pharmaceutical M&A deal ever (after the $87 billion merger of Warner-Lambert and Pfizer (NYSE: PFE) twenty years ago). Despite the price tag, it was still a bargain. Even though BMY offered a 53.7% premium to CELG’s closing price on January 2, the latter, which lost $30 per share between August 30, 2018, and year-end, still trades below its 52-week high. This price action shows how unexpected the deal was, and how little of the future M&A premium was “baked” into the price of CELG before BMY has made its move. Identifying potential M&A targets is a difficult process, but it can be worth the effort. After all, a jump of 30%, 50% or even more is a nice payoff… But it’s never wise to simply invest in a stock on the hopes that it will one day be acquired — hence the research part.  —Recommended Link— 9… Read More

Here at StreetAuthority, we spend a great deal of our research efforts digging through hundreds of investment ideas, SEC filings, earnings reports and analyst reports so we can identify what we believe are the best investment opportunities for our subscribers. We wouldn’t continually waste our efforts if it didn’t prove fruitful. Over the years our hard work has delivered some incredible gains for our premium readers. And perhaps no single piece of research we do has been more profitable for more people than our annual Top 10 Stocks report for the coming year. —Recommended Link— How I hacked the stock… Read More

Here at StreetAuthority, we spend a great deal of our research efforts digging through hundreds of investment ideas, SEC filings, earnings reports and analyst reports so we can identify what we believe are the best investment opportunities for our subscribers. We wouldn’t continually waste our efforts if it didn’t prove fruitful. Over the years our hard work has delivered some incredible gains for our premium readers. And perhaps no single piece of research we do has been more profitable for more people than our annual Top 10 Stocks report for the coming year. —Recommended Link— How I hacked the stock market and got away with $37,000 One of my readers told me “[He] had zero experience but made approximately $40,000 in 2 years.” Click here for the easy (and legal) secret…… This report, which is produced by the Top Stock Advisor research team, has proven to be one the most anticipated pieces of research we produce each year. When we first started this ambitious project in 2003, our stocks beat the market by twelve percentage points. Then in 2004… 2005… 2006… 2007… we trounced the market. In the market crash of 2008, we saw losses like everyone else… Read More

In 1851, Henry Jarvis Raymond and George Jones founded the New-York Daily Times. The paper sold for a penny. By 1857, the company changed its name to The New-York Times. It wasn’t until 1896 that it dropped the hyphen. Finally, in 1969, The New York Times (NYSE: NYT) became a publicly traded company. Contrary to what you may have heard a certain U.S. President claim, the New York Times is hardly failing. In fact, I think it may be one of the next big winners we have over at my premium service, Maximum Profit.  Here’s why… The Case For NYT… Read More

In 1851, Henry Jarvis Raymond and George Jones founded the New-York Daily Times. The paper sold for a penny. By 1857, the company changed its name to The New-York Times. It wasn’t until 1896 that it dropped the hyphen. Finally, in 1969, The New York Times (NYSE: NYT) became a publicly traded company. Contrary to what you may have heard a certain U.S. President claim, the New York Times is hardly failing. In fact, I think it may be one of the next big winners we have over at my premium service, Maximum Profit.  Here’s why… The Case For NYT The news organization is the third most widely-distributed circulated paper in the United States, behind USA Today and The Wall Street Journal. It’s been awarded 125 Pulitzer Prizes, more than any other news organization. The New York Times has thrived in a world where it’s seen many of its peers fail.  For example, The Tribune Company, which owns the Chicago Tribune and, until recently, the Los Angeles Times, filed for bankruptcy in 2008. And it’s not alone: Newsroom employment has dropped by more than 20,000 in the past 15 years, and newspaper circulation is at its lowest level since… Read More

With the tenth anniversary of this bull market upon us, investors have a lot to celebrate. Stocks are up, profits are growing, the economy is chugging along, the interest rate environment is relatively benign, and even on the trade-war front we are seeing some positive expectations lately. There’s nothing more bullish than a bull market. If this saying is even half-correct, the best indication we investors have that the market strength will continue is the powerful market rebound off the latest lows in December 2018. The chart below, which extends from Dec 24, 2018, to March 5, 2019, shows the… Read More

With the tenth anniversary of this bull market upon us, investors have a lot to celebrate. Stocks are up, profits are growing, the economy is chugging along, the interest rate environment is relatively benign, and even on the trade-war front we are seeing some positive expectations lately. There’s nothing more bullish than a bull market. If this saying is even half-correct, the best indication we investors have that the market strength will continue is the powerful market rebound off the latest lows in December 2018. The chart below, which extends from Dec 24, 2018, to March 5, 2019, shows the power of that rebound rally. From the market’s low on Christmas Eve, all the major U.S. indices rallied quite strongly. Here’s the grand total… #-ad_banner-#Not counting dividends, the Dow Jones Industrial Average advanced 18.4%, falling slightly behind the S&P 500’s 18.7% return. Not to be outdone, the Russell 2000 index of small-cap stocks has been leading the rebound with its 23.8% return as of March 5. The tech-heavy Nasdaq 100 has also done very well, with a 21.3% return over these two and a half months. I’m happy to report that our portfolio over at Game-Changing Stocks has done quite… Read More

A body in motion tends to stay in motion. Unless, of course, an external force is applied. Add “stock market advisor” to Isaac Newton’s resume, right along with astronomer, physicist and mathematician. Similar to physics, Newton’s first law of motion also works in investments. Kind of. While there is no physical force that moves them, stocks, much like physical objects, tend to continue moving in the same direction until something around them (or about them) changes. No one — including Newton — can or could with a high degree of certainty predict this afternoon’s breaking news or tomorrow’s big earnings… Read More

A body in motion tends to stay in motion. Unless, of course, an external force is applied. Add “stock market advisor” to Isaac Newton’s resume, right along with astronomer, physicist and mathematician. Similar to physics, Newton’s first law of motion also works in investments. Kind of. While there is no physical force that moves them, stocks, much like physical objects, tend to continue moving in the same direction until something around them (or about them) changes. No one — including Newton — can or could with a high degree of certainty predict this afternoon’s breaking news or tomorrow’s big earnings upset. What investors can do, however, is follow the trend. That’s why I recently set out with a goal to investigate stocks that are moving higher. To do this, I screened all U.S.-listed small-cap stocks (those with market capitalizations less than $2 billion but larger than $500 million) that have closed within 5% of their 52-week high. To make this screen more relevant to the goals of my Game-Changing Stocks premium newsletter, I also wanted to screen for future — expected — growth. Because this metric is based on analysts’ assessments, I also looked for stocks that were covered by… Read More

It’s good to have the best seat in the house… In all of my years at StreetAuthority, I’ve been fortunate enough to watch some of the brightest financial minds at work in this business. And every so often I like to take the spotlight and shine it exclusively on one of our premium newsletter analysts. —Recommended Link— MiracleBlood postpones old age by 50 years The full details are in our new podcast, but believe me when I say that this is huge. Click here to listen for free. I’ve done this a number of times. Often it’s in the… Read More

It’s good to have the best seat in the house… In all of my years at StreetAuthority, I’ve been fortunate enough to watch some of the brightest financial minds at work in this business. And every so often I like to take the spotlight and shine it exclusively on one of our premium newsletter analysts. —Recommended Link— MiracleBlood postpones old age by 50 years The full details are in our new podcast, but believe me when I say that this is huge. Click here to listen for free. I’ve done this a number of times. Often it’s in the form of one-on-one interviews. On other rare occasions, I’ll hand the reins of these pages over to the analyst so that they can speak directly, personally, to you. When it comes to an in-depth look at a winning strategy or important issue that could fundamentally change the way you think about investing, I’ve found that there’s simply no better way to get the message across than to sit down with one of our experts and have a detailed discussion. And judging from the feedback I’ve received over the years from you, our StreetAuthority Daily readers, a lot of you agree. Read More

Investing is a hard business. You can’t take anything for granted, and there is no easy and fast formula to predict how well a stock will do. It’s hard to determine whether a company — even a leader in a steady-as-it-goes business — will continue to deliver profits or appreciate versus the competition.  Case in point: Kraft Heinz (Nasdaq: KHC). This consumer-staple company has turned out to be anything but safe and steady. You’ve likely heard by now that shares of the world’s fifth-largest food-and-drinks company lost 27% in a single session on Friday, February 22. And Kraft halved its… Read More

Investing is a hard business. You can’t take anything for granted, and there is no easy and fast formula to predict how well a stock will do. It’s hard to determine whether a company — even a leader in a steady-as-it-goes business — will continue to deliver profits or appreciate versus the competition.  Case in point: Kraft Heinz (Nasdaq: KHC). This consumer-staple company has turned out to be anything but safe and steady. You’ve likely heard by now that shares of the world’s fifth-largest food-and-drinks company lost 27% in a single session on Friday, February 22. And Kraft halved its dividend, too. A whopping $15.4 billion write-down of its acquisitions of Kraft and Oscar Mayer was just part of the bad news; the company also disclosed a U.S. Securities and Exchange Commission (SEC) investigation of its procurement accounting practices. Talk about risky…  Before that one-day nosedive, KHC had already lost about half of its value. And now, even Warren Buffett, arguably the best investor in the business, laments that he overpaid for Kraft (Berkshire Hathaway owns 26.7% of the company and lost more than $4.3 billion on that fateful Friday). (This article from CNBC gives a… Read More

One of the goals I have in mind when screening for stocks is to find fresh investment ideas — ideas that have not been preconceived or predetermined by an analyst’s current thinking and market outlook. These screens also generate new and sometimes unexpected ideas for my Fast-Track Millionaire readers to consider.  Recently, I showed my subscribers the results of a screen I ran for financially healthy mid-cap companies (market capitalization between $2 billion and $10 billion) that have been outgrowing the rest of the pack. And today, I’m going to share it with you… —Recommended Link— What would YOU do… Read More

One of the goals I have in mind when screening for stocks is to find fresh investment ideas — ideas that have not been preconceived or predetermined by an analyst’s current thinking and market outlook. These screens also generate new and sometimes unexpected ideas for my Fast-Track Millionaire readers to consider.  Recently, I showed my subscribers the results of a screen I ran for financially healthy mid-cap companies (market capitalization between $2 billion and $10 billion) that have been outgrowing the rest of the pack. And today, I’m going to share it with you… —Recommended Link— What would YOU do with an extra $3,080 every month for the rest of your life? Never worry about cash again. Be free to live how YOU want… go on a lavish vacation… or build up a college fund for the grandkids–it’s up to you. Get your share here…. The Criteria Screening for growth might seem easy, but there are many ways to go about it. For this screen, I’ve chosen a relatively straightforward way to measure growth, a method that would also allow us to include younger companies that could have been unprofitable over the past few years. Only companies with… Read More

It’s hard to underestimate the importance of understanding business and financial trends for successful investing. After all, it’s hard to be an effective investor if all you watch are the stocks in your portfolio. This is why analysts, market watchers and researchers always try to understand industry trends and follow a great number of stocks comprising sectors of interest. Over the past few weeks, I’ve been telling readers about one trend that’s definitely worth watching — namely, the developments in the burgeoning field of “personalized medicine.” Why is it so important? Here’s what I said in that article: “…we find… Read More

It’s hard to underestimate the importance of understanding business and financial trends for successful investing. After all, it’s hard to be an effective investor if all you watch are the stocks in your portfolio. This is why analysts, market watchers and researchers always try to understand industry trends and follow a great number of stocks comprising sectors of interest. Over the past few weeks, I’ve been telling readers about one trend that’s definitely worth watching — namely, the developments in the burgeoning field of “personalized medicine.” Why is it so important? Here’s what I said in that article: “…we find ourselves on the cusp of another generational shift in medicine — one that could not only lead to longer, healthier lives for a lot of us… but one that stands to make a fortune for investors with the foresight to get in on the early stages.” Make no mistake, if there is one area you want to pay attention to over the coming months and years, this is it… —Recommended Link— Hit This “Sweet Spot” For 9.9% Average Yields While you might be tempted to buy only the highest-yielding dividend stocks… please DON’T. Because research proves that one special… Read More

Shares of cyber-security company Mimecast (Nasdaq: MIME) shot up about 20% on February 12, establishing a new all-time high in the process. The catalyst: a third-quarter earnings report that showed the company continues to excel on all fronts. If you purchased MIME when I recommended it in my Game-Changing Stocks service a little over a year ago, you’re sitting on an 80% gain right now. Before I touch on what’s sparked the recent rally, I want to highlight what exactly Mimecast does, for those who aren’t premium subscribers.  Leveraging The Cloud Mimecast, which went public in November 2015, is… Read More

Shares of cyber-security company Mimecast (Nasdaq: MIME) shot up about 20% on February 12, establishing a new all-time high in the process. The catalyst: a third-quarter earnings report that showed the company continues to excel on all fronts. If you purchased MIME when I recommended it in my Game-Changing Stocks service a little over a year ago, you’re sitting on an 80% gain right now. Before I touch on what’s sparked the recent rally, I want to highlight what exactly Mimecast does, for those who aren’t premium subscribers.  Leveraging The Cloud Mimecast, which went public in November 2015, is a bright young company in the business of enabling, securing and protecting cloud-based email for a variety of companies.  #-ad_banner-#As you probably know, moving to the cloud is one of the most important business trends of the past decade. Organizations that use the cloud benefit from the flexibility of the services, the usage-based subscription model, the lowered capital expenses and the improved accessibility for remote or dispersed employees. But dangers abound… Data breaches. Compromised credentials. Hacked accounts. Data loss from an attack. These are just a few examples of things that can go wrong.  Some of these threats stem from… Read More